Related Experiment Video
Updated: May 16, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Rheumatoid Arthritis: A Comprehensive Review of Etiology, Pathophysiology, and Innovative Therapeutic Advancements
Ajay Karabhari1, Sunny Rathee2, Sakshi Soni2
1College of Pharmaceutical Sciences (COPS), School of Health Sciences, Dayananda Sagar University, Devarakaggalahalli, Harohalli, Kanakapura Road, Ramanagara Dt., Bengaluru, Karnataka, 562112, India.
Current Pharmaceutical Design
|May 15, 2026
Summary
Rheumatoid arthritis (RA) involves complex genetics and environmental factors, leading to joint damage. Novel nanotechnology and precision medicine approaches offer improved treatment efficacy and reduced side effects for RA patients.
Area of Science:
- Immunology
- Rheumatology
- Nanotechnology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting 1% of the global population, causing joint inflammation, cartilage degradation, and bone erosion.
- RA pathogenesis involves genetic predisposition, environmental triggers (smoking, obesity, dysbiosis), and immune dysregulation, including T cell, B cell, and cytokine (TNF-α, IL-6) activation.
- Current treatments like DMARDs and biologics improve outcomes but face limitations in non-responsive patients and long-term safety concerns.
Purpose of the Study:
- To review the multifactorial etiology and immunopathogenesis of rheumatoid arthritis.
- To explore emerging therapeutic strategies and novel drug delivery systems for RA management.
- To highlight the potential of precision medicine and personalized treatments in revolutionizing RA care.
Main Methods:
- Comprehensive literature review of rheumatoid arthritis etiology, pathogenesis, and treatment.
- Analysis of recent advances in nanotechnology, biomimetic drug carriers, and precision medicine for RA.
- Examination of innovative therapeutic approaches including hydrogels, liposomal systems, and nanoparticle-based immune modulation.
Main Results:
- RA involves a complex interplay of genetic and environmental factors leading to chronic inflammation and joint destruction.
- Conventional therapies have limitations, necessitating the exploration of advanced treatment modalities.
- Nanotechnology and precision medicine offer promising avenues for enhanced drug delivery, improved efficacy, and reduced systemic side effects in RA treatment.
Conclusions:
- Emerging therapeutic strategies leveraging nanotechnology and personalized medicine hold significant potential for revolutionizing rheumatoid arthritis management.
- Innovative drug delivery systems can improve treatment efficacy and mitigate adverse effects associated with conventional RA therapies.
- A deeper understanding of RA's complex pathogenesis is crucial for developing targeted and effective personalized treatment approaches.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...